Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
汉堡包应助郭郭采纳,获得10
刚刚
丘比特应助Zjx采纳,获得10
1秒前
2秒前
无情向薇发布了新的文献求助10
3秒前
keep发布了新的文献求助10
4秒前
Nn发布了新的文献求助10
4秒前
搜集达人应助薛人英采纳,获得10
5秒前
yue发布了新的文献求助10
6秒前
辛勤的寄瑶完成签到 ,获得积分10
6秒前
10秒前
coolkid应助科研通管家采纳,获得10
10秒前
桐桐应助科研通管家采纳,获得10
11秒前
绝情继父应助科研通管家采纳,获得10
11秒前
Ava应助科研通管家采纳,获得10
11秒前
慕青应助科研通管家采纳,获得10
11秒前
SYLH应助科研通管家采纳,获得10
11秒前
11秒前
wanci应助科研通管家采纳,获得10
11秒前
coolkid应助科研通管家采纳,获得10
11秒前
coolkid应助科研通管家采纳,获得10
11秒前
田様应助科研通管家采纳,获得10
12秒前
搜集达人应助科研通管家采纳,获得10
12秒前
12秒前
12秒前
12秒前
12秒前
Lucas应助科研通管家采纳,获得10
12秒前
12秒前
12秒前
12秒前
小憩发布了新的文献求助10
15秒前
花生完成签到,获得积分10
19秒前
22秒前
22秒前
小嘎完成签到 ,获得积分10
22秒前
23秒前
木棉完成签到,获得积分20
25秒前
百里健柏完成签到,获得积分10
28秒前
文静小凝发布了新的文献求助30
28秒前
GSQ发布了新的文献求助10
29秒前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
Indomethacinのヒトにおける経皮吸収 400
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 370
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3993104
求助须知:如何正确求助?哪些是违规求助? 3534001
关于积分的说明 11264385
捐赠科研通 3273705
什么是DOI,文献DOI怎么找? 1806142
邀请新用户注册赠送积分活动 883016
科研通“疑难数据库(出版商)”最低求助积分说明 809652